Extended Data Fig. 2: Progression-free and overall survival.

Kaplan-Meier estimates for patients in the NSCLC cohort for A. Progression-free survival and B. Overall survival. Kaplan-Meier estimates for patients in the melanoma cohort for C. Progression-free survival and D. Overall survival.